Sandoz stock: generic drugmaker trades pre-market at EUR 82.10
Published on 10/20/2026 at 08:15 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSSales date and business model
- Sandoz develops, manufactures and markets generic and biosimilar medicines.
- Sandoz’s calendar lists a sales and revenue release for October 27, 2026.
- Sandoz stock trades pre-market at EUR 82.10 at 8:12 a.m. CEST at Lang & Schwarz on October 20, 2026.
Sandoz develops, manufactures and markets generic and biosimilar medicines. Sandoz stock trades pre-market at EUR 82.10 at 8:12 a.m. CEST at Lang & Schwarz on October 20, 2026.
Ahead of the Xetra open
The pre-market bid was EUR 81.76 and the ask was EUR 82.44. The further course from the Xetra open at 9:00 a.m. CEST is shown by the continuously updated real-time quote of Sandoz stock.
What is on today
Sandoz operates in generics and biosimilars, developing, manufacturing and marketing medicines in these businesses, according to MarketScreener. The same calendar lists a sales and revenue release for October 27, 2026. Market context: Market report SMI.
Disclaimer...
en | CH1243598427 | SANDOZ | boerse | 70369239 | bgmi
